Strategic Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Strategic Advisors's AMGN Position: Q2 2026 in Review
Strategic Advisors increased its Amgen (AMGN) stake by 0.31% in Q2 2026, buying an estimated $685 and bringing the position to 645 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #155.
Strategic Advisors first reported a position in AMGN in Q1 2017 and has held it in 26 quarters since. The position peaked at $7.39M in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Strategic Advisors held 645 shares of Amgen worth $234K as of Q2 2026.
- Strategic Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.05% of Strategic Advisors's portfolio in Q2 2026, its #155 holding.
- Strategic Advisors first reported a position in Amgen in Q1 2017 and has held it in 26 quarters since.
- Strategic Advisors's Amgen position peaked at $7.39M in Q4 2023.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.